Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42,138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Insulin signaling establishes a developmental trajectory of adipose regulatory T cells.
Li Y, Lu Y, Lin SH, Li N, Han Y, Huang Q, Zhao Y, Xie F, Guo Y, Deng B, Tsun A, Du J, Li D, Sun J, Shi G, Zheng F, Su X, Duan S, Zheng SG, Wang G, Tong X, Li B. Li Y, et al. Among authors: sun j. Nat Immunol. 2021 Sep;22(9):1175-1185. doi: 10.1038/s41590-021-01010-3. Epub 2021 Aug 24. Nat Immunol. 2021. PMID: 34429546
Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer.
Zhai T, Wang C, Xu Y, Huang W, Yuan Z, Wang T, Dai S, Peng S, Pang T, Jiang W, Huang Y, Zou Y, Xu Y, Sun J, Gong X, Zhang J, Tsun A, Li B, Miao X. Zhai T, et al. Among authors: sun j. J Immunother Cancer. 2021 Jun;9(6):e002131. doi: 10.1136/jitc-2020-002131. J Immunother Cancer. 2021. PMID: 34172514 Free PMC article.
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.
Miao X, Luo Y, Huang X, Lee SMY, Yuan Z, Tang Y, Chen L, Wang C, Wu F, Xu Y, Jiang W, Gao W, Song X, Yan Y, Pang T, Chen C, Zou Y, Fu W, Wan L, Gilbert-Jaramillo J, Knight M, Tan TK, Rijal P, Townsend A, Sun J, Liu X, James W, Tsun A, Xu Y. Miao X, et al. Among authors: sun j. MAbs. 2020 Jan-Dec;12(1):1804241. doi: 10.1080/19420862.2020.1804241. MAbs. 2020. PMID: 32804015 Free PMC article.
Analytical comparability study of recombinant monoclonal antibody therapeutics.
Ambrogelly A, Gozo S, Katiyar A, Dellatore S, Kune Y, Bhat R, Sun J, Li N, Wang D, Nowak C, Neill A, Ponniah G, King C, Mason B, Beck A, Liu H. Ambrogelly A, et al. Among authors: sun j. MAbs. 2018 May/Jun;10(4):513-538. doi: 10.1080/19420862.2018.1438797. Epub 2018 Mar 20. MAbs. 2018. PMID: 29513619 Free PMC article. Review.
Structure, heterogeneity and developability assessment of therapeutic antibodies.
Xu Y, Wang D, Mason B, Rossomando T, Li N, Liu D, Cheung JK, Xu W, Raghava S, Katiyar A, Nowak C, Xiang T, Dong DD, Sun J, Beck A, Liu H. Xu Y, et al. Among authors: sun j. MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17. MAbs. 2019. PMID: 30543482 Free PMC article. Review.
Boarding pyroptosis onto nanotechnology for cancer therapy.
Ban W, Chen Z, Zhang T, Du T, Huo D, Zhu G, He Z, Sun J, Sun M. Ban W, et al. Among authors: sun j. J Control Release. 2024 May 10:S0168-3659(24)00298-0. doi: 10.1016/j.jconrel.2024.05.014. Online ahead of print. J Control Release. 2024. PMID: 38735396 Review.
42,138 results
You have reached the last available page of results. Please see the User Guide for more information.